Jazz Pharmaceuticals to Host Modeyso™ (dordaviprone) Investor Webcast on August 27, 2025

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

Jazz-Pharmaceuticals

More Like This

PR Newswire associated0

Jazz Pharmaceuticals Completes Acquisition of Chimerix

PR Newswire associated0

Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio

PR Newswire associated0

Jazz Pharmaceuticals Announces Ziihera® (zanidatamab-hrii) Investor Webcast on December 11, 2024

PR Newswire associated0

Jazz Pharmaceuticals to Host Virtual Zanidatamab R&D Day on Tuesday, March 19, 2024

PR Newswire associated0

Jazz Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference

PR Newswire associated0

Jazz Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference

PR Newswire associated0

Menarini Group Announces New Data on ORSERDU® (elacestrant) at the 2023 San Antonio Breast Cancer Symposium and on ELZONRIS® (tagraxofusp-erzs) at the 65th American Society of Hematology Annual Meeting and Exposition

PR Newswire associated0

Jazz Pharmaceuticals to Participate in Three Upcoming Investor Conferences